http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022062367-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed30e0cd0f26cf0a06d92a1beefde3f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-71
filingDate 2021-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_934d6027fe7c8262226cb64895a06b50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0b7fbefed0e5407ca11c7667973475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a44875ca4823425e05b2fd874b268029
publicationDate 2022-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022062367-A1
titleOfInvention Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline
abstract Disclosed are compositions of matter, treatments and protocols useful for induction of T regulatory cells in response to inflammation, as well as inhibition of suicidal ideations and/or neuroinflammation. In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of minocycline, pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal undergoing upregulation of inflammatory mediators. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with said SARS-CoV-2 and/or possessing suicidal ideations. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients.
priorityDate 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229674-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6602383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226479786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228991315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226479785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228991310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226694720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226852160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9577379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54749604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9992576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72277

Total number of triples: 58.